Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Characterization and Clinical Management of Dilated Cardiomyopathy
| Characterization and Clinical Management of Dilated Cardiomyopathy |
| Autore | Merlo Marco |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (232 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
SCN5A
cardiac sodium channel cardiac channelopathy dilated cardiomyopathy precision medicine arrhythmias atrial fibrillation cardiomyopathy heart failure supraventricular arrhythmia systolic dysfunction tachycardiomyopathy ventricular arrhythmia left atrial strain cardiac resynchronization therapy muscular dystrophy calcium heart gene therapy phospholamban Serca2a mdx oxidative stress membrane stabilization left ventricular noncompaction congenital heart disease congestive heart failure non-ischemic cardiomyopathy genetics desmin mitochondrial dysfunction myopathy whole exome sequencing laminopathy LMNA biomarkers troponin T NT-proBNP malignant ventricular arrhythmia arrhythmic risk stratification DNA methylation alternative splicing epigenetics nonischemic dilated cardiomyopathy cardiac magnetic resonance imaging late gadolinium enhancement long axis strain left ventricle sphericity index major adverse cardiovascular events sex differences left ventricular reverse remodelling long-term outcomes left ventricle non-compaction cardiomyopathy cardiac magnetic resonance titin RNA binding motif protein 20 (RBM20) sarcomere diastolic dysfunction phosphorylation non-sense mRNA decay mammalian target of rapamycin (mTOR) complex-1 duchenne muscular distrophy |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557595503321 |
Merlo Marco
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and Management of Heart Failure
| Diagnosis and Management of Heart Failure |
| Autore | Gladysheva Inna P |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (202 p.) |
| Soggetto topico |
Medicine
Cardiovascular medicine |
| Soggetto non controllato |
biomarkers
ST-segment elevation myocardial infarction preserved left ventricular ejection fraction reduced left ventricular ejection fraction heart failure NT-proBNP soluble ST2 galectin-3 matrix metalloproteinases tissue inhibitors of metalloproteinases mortality ejection fraction cardiopulmonary exercise test ventilatory inefficiency angiotensin receptor-neprilysin inhibitor echocardiography HFrEF risk stratification left ventricle end-diastolic diameter E/e' ratio left ventricle outflow tract velocity-time integral hospitalization predictor short-term prognosis heart failure readmission acute myocardial infarction blood biomarkers diagnosis congestion clinical assessment preserved ejection fraction type 2 diabetes mellitus myocardial infarction chronic heart failure heart rate variability 2D echocardiography 24-h ECG monitoring chronic kidney disease pulmonary hypertension arteriovenous fistulas overhydration heart transplant cardiac allograft vasculopathy heart transplant rejection transthoracic echocardiography longitudinal strain sensing parameters pacing parameters adverse left ventricular remodeling left ventricular-arterial coupling fatty liver cardiovascular disease fibrosis epicardial fat left atrial strain edema dilated cardiomyopathy fluid management endothelial dysfunction |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576881803321 |
|
Gladysheva Inna P
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and management of pediatric diseases / / special issue editor, Consolato M. Sergi University of Alberta, Edmonton Canada
| Diagnosis and management of pediatric diseases / / special issue editor, Consolato M. Sergi University of Alberta, Edmonton Canada |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (146 p.) |
| Disciplina | 618.92 |
| Soggetto topico |
Children - Diseases
Pediatrics |
| Soggetto non controllato |
interferon signature score
interferonopathies rat model pulmonary hypertension neurological symptoms early-onset sarcoidosis sialidosis sialidosis I children mediastinitis bilirubin encephalopathy Blau syndrome myocardial dysfunction cardiopulmonary bypass neuropathology bacteremia tissue doppler imaging HD-OCT biostatistics continuous insulin infusion system infants RNFL biomarkers diagnosis somatosensory evoked potential Paediatric sarcoidosis diabetic retinopathy brain damage tonsillectomy hybrid closed-loop system cytopathology neuraminidase subcutaneous emphysema continuous glucose monitor respiratory syncytial virus data sharing complication lysosomal storage disease echocardiography ONH systemic lupus erythematosus NT-proBNP preterm brain head and neck inter-laboratory variability GSH insulin pump high-risk sarcoidosis type 1 diabetes hypoxia-ischemia Tei index sialidosis II mediastinal emphysema newborn diabetes technology diagnostics lysosomal exocytosis kernicterus cerebral palsy choroidal thickness oxidative stress |
| ISBN | 3-03921-967-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367738603321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Basis of Cardiovascular Diseases: Implications of Natriuretic Peptides
| Molecular Basis of Cardiovascular Diseases: Implications of Natriuretic Peptides |
| Autore | Rubattu Speranza |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (212 p.) |
| Soggetto non controllato |
postmortem biochemistry
medulla animal models remodeling BNP PCSK9 guanylyl cyclase/natriuretic peptide receptor-A cardiorenal syndrome forensic medicine preserved ejection fraction kidney renin-angiotensin-aldosterone system atrial fibrillation vasopressor congestive heart failure atrial natriuretic peptide gene-knockout obesity heart failure angiogenesis adipose tissue vascular LDL receptor metabolic syndrome linkage analysis cardiometabolic disease cardiomyocyte cardiac dysfunction cardiac hypertrophy insulin lipid metabolism cGMP Idiopathic Pulmonary Arterial Hypertension (IPAH) Natriuretic Peptide Clearance Receptor (NPR-C) signaling gene-duplication renin–angiotensin system natriuretic peptides angiotensin receptor–neprilysin inhibitor cardiac remodelling ARNi NT-proBNP inflammation pulmonary arterial hypertension vascular homeostasis endothelial cell Atrial Natriuretic peptide natriuretic peptide vasodilator stroke genetic variants arterial hypertension fibroblast MANP hypertension guanylyl cyclase receptor A |
| ISBN | 3-03921-583-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Molecular Basis of Cardiovascular Diseases |
| Record Nr. | UNINA-9910367751403321 |
|
Rubattu Speranza
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
diet quality
ceramides obesity cardiovascular risk healthy eating index carbohydrate antigen-125 heart failure inflammatory marker older women biomarker cardiometabolic disease epicardial adipose tissue epicardial fat epicardial fat volume microRNA thyroid-stimulating hormone cardiometabolic risks metabolic syndrome hypertension very low-density lipoprotein STIM1 SOCE atrial myopathy atrial fibrillation ejection fraction soluble urokinase-type plasminogen activator receptor (suPAR) growth differentiation factor 15 (GDF-15) heart-type fatty acid-binding protein (H-FABP) soluble suppression of tumorigenicity 2 (sST2) acute myocardial infarction biomarkers catestatin coronary artery disease heart failure decompensation left ventricular ejection fraction troponin NT-proBNP NYHA functional class GDF-15 cardiovascular surgery operative risk muscle wasting sarcopenia renal dysfunction chronic kidney disease aortic disease aneurysm miRNA TGF-β pathway KLF4 synthetic phenotype aortic regurgitation echocardiography magnetic resonance imaging vena contracta area longitudinal strain T1 mapping GDF8 myostatin AMI ceruloplasmin H-FABP heart-type fatty acid-binding protein FABP3 fatty acid-binding protein 3 HF cardiac biomarkers cardiac magnetic resonance imaging left ventricular systolic function magnetic resonance spectroscopy myocardial triglyceride content cell adhesion molecule repeated measurements pregnancy-associated plasma protein-A cohort studies cardiovascular diseases mitochondrial dysfunction circulating cells PBMCS platelets oxidative stress reactive oxygen species (ROS) mitochondrial DNA (mtDNA) herat failure liver-type fatty-acid-binding protein long-term outcomes cardiac intensive care units acute kidney injury myocardial infarction STEMI cardiovascular events cardiovascular death risk stratification sST2 Pentraxin-3 sudden cardiac death ventricular arrhythmia ventricular tachycardia chronic heart failure saliva salivary biomarkers CKD CVD PPCI left ventricular adverse remodelling circulating miRNAs NAFLD Framingham risk score risk prediction secondary prevention primary prevention NAFLD fibrosis score HFpEF HFrEF suPAR |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
|
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice
| Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice |
| Autore | Taranta-Janusz Katarzyna |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (304 p.) |
| Soggetto topico |
Medicine
Clinical & internal medicine |
| Soggetto non controllato |
chronic kidney disease
cytokines solitary functioning kidney tumor necrosis factor-like weak inducer of apoptosis netrin-1 renal tubular damage premature newborns overactive bladder urinary microbiome children adolescents cystatin C galectin-3 periostin primary hypertension arterial damage blood pressure neurogenic bladder myelomeningocele markers furosemide stress test hyperfiltration [IGFBP-7] × [TIMP-2] NGAL renal angina index renal functional reserve tubular damage tubuloglomerular feedback neurotrophins transcutaneous electrical nerve stimulation hemopexin nephrotic syndrome HNF1B hyperuricemia PTH renal function uric acid FEUA sclerostin obesity childhood dental caries gingivitis kidney injury glomerulopathy glomerular injury alpha-1 acid glycoprotein urinary mRNA expression of podocyte-associated proteins cathepsin B premature neonates immaturity NT-proBNP cardiovascular disease common carotid artery intima-media thickness bone morphogenetic protein (BMP)-2 bone morphogenetic protein (BMP)-6 extracellular matrix metalloproteinases inducer (EMMPRIN) macrophage migration inhibitory factor (MIF) tubular functional reserve cytokeratin-18 endoglin transforming growth factor-β1 renal fibrosis congenital obstructive nephropathy diabetic kidney disease vascular endothelial markers eGFR adenine nucleotide metabolites chronic renal failure antibiotic resistance Escherichia coli inflammatory markers urinary tract infection B2M cancer CCS CKD nephropathies renal toxicity voiding cystography infection urinary tract IgA nephropathy IgA vasculitis with nephritis vanin-1 biomarker urinary tract infections artificial intelligence machine learning medical decision support system |
| ISBN | 3-0365-5974-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Pediatric and Adolescent Nephrology Facing the Future |
| Record Nr. | UNINA-9910639989903321 |
|
Taranta-Janusz Katarzyna
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||